Page last updated: 2024-08-21

alpha-aminopyridine and arsenic trioxide

alpha-aminopyridine has been researched along with arsenic trioxide in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Bashash, D; Delshad, M; Momeny, M; Pourbagheri-Sigaroodi, A; Riyahi, N; Safaroghli-Azar, A1
Alipour, F; Bashash, D; Riyahi, N; Safaroghli-Azar, A; Sari, S; Zandi, Z1
Naoe, T1

Reviews

1 review(s) available for alpha-aminopyridine and arsenic trioxide

ArticleYear
<Editors' Choice> How to improve outcomes of elderly patients with acute myeloid leukemia: era of excitement.
    Nagoya journal of medical science, 2020, Volume: 82, Issue:2

    Topics: Aged; Aged, 80 and over; Aminopyridines; Aniline Compounds; Antineoplastic Agents; Arsenic Trioxide; Azacitidine; Benzimidazoles; Bridged Bicyclo Compounds, Heterocyclic; Decitabine; fms-Like Tyrosine Kinase 3; Humans; Isocitrate Dehydrogenase; Leukemia, Myeloid, Acute; Molecular Targeted Therapy; Phenylurea Compounds; Precision Medicine; Proto-Oncogene Proteins c-bcl-2; Pyrazines; Smoothened Receptor; Staurosporine; Sulfonamides; Survival Rate; Tretinoin; Triazines

2020

Other Studies

2 other study(ies) available for alpha-aminopyridine and arsenic trioxide

ArticleYear
Inhibition of PI3K signaling pathway enhances the chemosensitivity of APL cells to ATO: Proposing novel therapeutic potential for BKM120.
    European journal of pharmacology, 2018, Dec-15, Volume: 841

    Topics: Aminopyridines; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Caspase 3; Cell Cycle; Cell Proliferation; Dose-Response Relationship, Drug; Drug Interactions; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Intracellular Space; Leukemia, Promyelocytic, Acute; Morpholines; Phosphatidylinositol 3-Kinases; Reactive Oxygen Species; Signal Transduction

2018
Inhibition of PI3K pathway using BKM120 intensified the chemo-sensitivity of breast cancer cells to arsenic trioxide (ATO).
    The international journal of biochemistry & cell biology, 2019, Volume: 116

    Topics: Aminopyridines; Anoikis; Antineoplastic Agents; Arsenic Trioxide; Cell Line; Cell Proliferation; DNA-Binding Proteins; Drug Combinations; Drug Synergism; Epithelial Cells; Female; Forkhead Transcription Factors; G1 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Morpholines; Phosphatidylinositol 3-Kinases; Phosphatidylserines; Signal Transduction; Survivin; Telomerase; Transcription Factors

2019